Facet browsing currently unavailable
Page 3 of 3821 results
Sort by: relevance publication year
Oligopeptide antagonist of IL-6: a novel approach to target IL-6 activities JOURNAL ARTICLE published October 2007 in Expert Opinion on Therapeutic Patents |
Tachykinin receptors in chronic inflammatory lower airway diseases JOURNAL ARTICLE published October 2007 in Expert Opinion on Therapeutic Patents |
Patent Evaluation: Furanoindotine antitumour agents JOURNAL ARTICLE published April 1994 in Expert Opinion on Therapeutic Patents |
Patent Evaluation Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Peptide inhibitors of C-X-C intercrines JOURNAL ARTICLE published February 1996 in Expert Opinion on Therapeutic Patents |
Patent Evaluation Cardiovascular & Renal: Novel aminoheterocyclic derivatives as inhibitors of factor Xa JOURNAL ARTICLE published August 1996 in Expert Opinion on Therapeutic Patents |
Antibodies to receptor activator of nuclear factor-κ B ligand (RANKL) JOURNAL ARTICLE published November 2008 in Expert Opinion on Therapeutic Patents |
Inhibitors of cathepsin G: a patent review (2005 to present) JOURNAL ARTICLE published December 2013 in Expert Opinion on Therapeutic Patents |
Novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: a patent review JOURNAL ARTICLE published February 2011 in Expert Opinion on Therapeutic Patents |
Coeliac disease. From A – Z JOURNAL ARTICLE published July 2007 in Expert Opinion on Therapeutic Patents |
Patent Analysis Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Interleukin-1 antagonists: patent analysis 1990–1995 JOURNAL ARTICLE published March 1996 in Expert Opinion on Therapeutic Patents |
Annotated Patent Selections JOURNAL ARTICLE published July 2000 in Expert Opinion on Therapeutic Patents |
Incyte Pharmaceuticals: the value of information JOURNAL ARTICLE published June 1997 in Expert Opinion on Therapeutic Patents |
Therapeutic domains of von Willebrand factor JOURNAL ARTICLE published May 1994 in Expert Opinion on Therapeutic Patents |
A novel structural motif for serine protease inhibitors JOURNAL ARTICLE published August 1999 in Expert Opinion on Therapeutic Patents |
Advances in the field of COX-2 inhibition JOURNAL ARTICLE published July 2002 in Expert Opinion on Therapeutic Patents |
Isolation and cloning of mammalian growth factor BTC-GF JOURNAL ARTICLE published February 1994 in Expert Opinion on Therapeutic Patents |
Ex vivofucosylation of stem cells to improve engraftment: WO2004094619 JOURNAL ARTICLE published September 2010 in Expert Opinion on Therapeutic Patents |
Growth hormone secretagogue receptor antagonists JOURNAL ARTICLE published June 2012 in Expert Opinion on Therapeutic Patents |
Small molecules as antagonists of co-inhibitory pathways for cancer immunotherapy: a patent review (2018-2019) JOURNAL ARTICLE published 1 September 2020 in Expert Opinion on Therapeutic Patents Research funded by National Cancer Institute (R21CA184788) | National Institutes of Health (P30CA022453) | Province Higher Educational Science and Technology (J17KA101) | Shandong Province Higher Educational Reformation Program (M2018X087) |
Recent developments of agents targeting Vibrio cholerae : patents and literature data JOURNAL ARTICLE published 11 March 2024 in Expert Opinion on Therapeutic Patents Research funded by EU funding within the NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (Project no. PE00000007) |